About the Company
We do not have any company description for Biohaven Ltd at the moment.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
77
Exchange
NEW YORK STOCK EXCHANGE INC.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BHVN News
Buy Rating Affirmed: Biohaven’s Innovative Pipeline and Financial Health Signal Promising Future
Analyst Brian Skorney of Robert W. Baird maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report), with a price target of $58.00. Brian Skorney has given his Buy rating due to a combination ...
Buy Rating Affirmed for Biohaven Ltd. on Strong Pipeline and Upcoming Drug Advancements
BTIG analyst Thomas Shrader maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report) yesterday and set a price target of $59.00.
Biohaven Ltd BHVN
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
RBC Capital Markets has initiated Biohaven Ltd (NYSE:BHVN), noting optimized development across programs. The analyst highlights the company’s way of identifying promising technologies and ...
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
and transaction-related costs incurred relating to the Company's spin-off from Biohaven Pharmaceutical Holding Company Ltd., which are limited to a specific period of time and related to Biohaven Ltd.
BHVN Factor-Based Stock Analysis
Below is Validea's guru fundamental report for BIOHAVEN LTD (BHVN). Of the 22 guru strategies we follow, BHVN rates highest using our Quantitative Momentum Investor model based on the published ...
A Look At The Intrinsic Value Of Biohaven Ltd. (NYSE:BHVN)
The projected fair value for Biohaven is US$45.86 based on 2 Stage ... of US$50.70 Does the February share price for Biohaven Ltd. (NYSE:BHVN) reflect what it's really worth?
Biohaven Reaches Analyst Target Price
In recent trading, shares of Biohaven Ltd (Symbol: BHVN) have crossed above the average analyst 12-month target price of $46.43, changing hands for $47.16/share. When a stock reaches the target an ...
Biohaven Pharmaceutical Holding Co Ltd (BHVN)
Biohaven Ltd. (BHVN) ("Biohaven"), announced the presentation of preclinical data demonstrating the ability of taldefgrobep alfa to significantly reduce fat mass while increasing ...
Biohaven Ltd.: Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
NEW HAVEN, Conn., Feb. 29, 2024 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), a global clinical-stage biopharmaceutical company focused on the discovery, development and ...
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
Morningstar brands and products Company Get 7 Days Free ...
Loading the latest forecasts...